Fortzaar Tablet 100 mg. 25 mg Tablets
PDF Leaflet Revision Date: 19 April 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension in patients on identical doses of individual agents.
Dosage (summary)
One tablet daily (100 mg losartan potassium and 25 mg hydrochlorothiazide).
Onset of Action / Duration
Onset: 3 weeks, Duration: Not specified.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Lithium
- NSAIDs
- Potassium-sparing diuretics
Contraindications
- Hypersensitivity
- Angioedema history
- Severe renal impairment
- Anuria
- Bilateral renal artery stenosis
- Aortic stenosis
- Addison's disease
Common side effects
- Dizziness
- Fatigue
- Headache
- Cough
- Palpitations
Counselling Points
- Monitor blood pressure regularly
- Avoid potassium supplements
- Report any signs of skin lesions
Serious warnings
- Risk of hypotension in volume-depleted patients
- Dual blockade of RAAS not recommended
Important Disclaimer
The Fortzaar Tablet 100 mg. 25 mg Tablets professional information leaflet below is the property of Organon South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
